Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (381-390 of 432) with videos related to

Pageof 44
Sort By:
Cephalalgia : an International Journal of Headache|May 23, 2025
Serum GFAP and NfL levels in migraine: A registry for migraine (REFORM) studyEmil Gozalov, William K Karlsson, Rune H Christensen, et al.
Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trialDavid W Dodick, Peter J Goadsby, Stephen D Silberstein, et al.
Nature Reviews. Neurology|July 12, 2023
The 5-HT<sub>1F</sub> receptor as the target of ditans in migraine - from bench to bedsideDimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 8, 2020
Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteersMohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Cherie Amalie Waldorff Nielsen, et al.
Cephalalgia : an International Journal of Headache|April 30, 2020
Vancouver Declaration II on Global Headache Patient Advocacy 2019David W Dodick, Messoud Ashina, Fumihiko Sakai, et al.
Brain : a Journal of Neurology|May 19, 2016
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI studyDavid Gaist, Ellen Garde, Morten Blaabjerg, et al.
Headache|April 25, 2022
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine preventionRichard B Lipton, Peter J Goadsby, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adultsCristina Tassorelli, Hans-Christoph Diener, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|April 3, 2026
Migraine induced by vascular K<sub>ATP</sub> channel activation is independent of HCN channel activity: A randomised controlled trial with translational validationZixuan Alice Zhuang, Janu Thuraiaiyah, Lili Kokoti, et al.
Pageof 44

Showing results (381-390 of 432) with videos related to

Sort By:
Pageof 44
Cephalalgia : an International Journal of Headache|May 23, 2025
Serum GFAP and NfL levels in migraine: A registry for migraine (REFORM) studyEmil Gozalov, William K Karlsson, Rune H Christensen, et al.
Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trialDavid W Dodick, Peter J Goadsby, Stephen D Silberstein, et al.
Nature Reviews. Neurology|July 12, 2023
The 5-HT<sub>1F</sub> receptor as the target of ditans in migraine - from bench to bedsideDimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 8, 2020
Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteersMohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Cherie Amalie Waldorff Nielsen, et al.
Cephalalgia : an International Journal of Headache|April 30, 2020
Vancouver Declaration II on Global Headache Patient Advocacy 2019David W Dodick, Messoud Ashina, Fumihiko Sakai, et al.
Brain : a Journal of Neurology|May 19, 2016
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI studyDavid Gaist, Ellen Garde, Morten Blaabjerg, et al.
Headache|April 25, 2022
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine preventionRichard B Lipton, Peter J Goadsby, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adultsCristina Tassorelli, Hans-Christoph Diener, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|April 3, 2026
Migraine induced by vascular K<sub>ATP</sub> channel activation is independent of HCN channel activity: A randomised controlled trial with translational validationZixuan Alice Zhuang, Janu Thuraiaiyah, Lili Kokoti, et al.
Pageof 44